PubMed:27172902 / 0-238
Annnotations
LitCoin-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-166 | Sentence | denotes | Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. |
LitCoin-entities
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
11281 | 0-9 | ChemicalEntity | denotes | Cisplatin | MESH:D002945 |
11282 | 61-64 | GeneOrGeneProduct | denotes | TLR | NCBIGene:13982 |
11283 | 105-110 | GeneOrGeneProduct | denotes | IL-10 | NCBIGene:16153 |
11284 | 203-212 | ChemicalEntity | denotes | cisplatin | MESH:D002945 |
LitCoin-GeneOrGeneProduct-v0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-9 | GeneOrGeneProduct | denotes | Cisplatin |
T2 | 10-17 | GeneOrGeneProduct | denotes | induces |
T3 | 40-45 | GeneOrGeneProduct | denotes | cells |
T4 | 91-101 | GeneOrGeneProduct | denotes | production |
T5 | 105-110 | GeneOrGeneProduct | denotes | IL-10 |
T6 | 139-142 | GeneOrGeneProduct | denotes | Tr1 |
T7 | 152-156 | GeneOrGeneProduct | denotes | cell |
T8 | 157-165 | GeneOrGeneProduct | denotes | immunity |
T9 | 176-180 | GeneOrGeneProduct | denotes | many |
T10 | 203-212 | GeneOrGeneProduct | denotes | cisplatin |
LitCoin-GeneOrGeneProduct-v2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-9 | GeneOrGeneProduct | denotes | Cisplatin |
T2 | 105-110 | GeneOrGeneProduct | denotes | IL-10 |
T3 | 152-156 | GeneOrGeneProduct | denotes | cell |
T4 | 157-165 | GeneOrGeneProduct | denotes | immunity |
T5 | 203-212 | GeneOrGeneProduct | denotes | cisplatin |
LitCoin-GeneOrGeneProduct-v3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 61-64 | GeneOrGeneProduct | denotes | TLR |
T2 | 105-110 | GeneOrGeneProduct | denotes | IL-10 |
LitCoin-Chemical-MeSH-CHEBI
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T1 | 0-9 | ChemicalEntity | denotes | Cisplatin | http://purl.obolibrary.org/obo/CHEBI_27899 |
T2 | 203-212 | ChemicalEntity | denotes | cisplatin | D002945|http://purl.obolibrary.org/obo/CHEBI_27899 |
LitCoin-NCBITaxon-2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 214-217 | OrganismTaxon | denotes | cis |
LitCoin-training-merged
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T2 | 203-212 | ChemicalEntity | denotes | cisplatin | http://purl.obolibrary.org/obo/CHEBI_27899|D002945 |
T1 | 0-9 | ChemicalEntity | denotes | Cisplatin | http://purl.obolibrary.org/obo/CHEBI_27899 |
T31928 | 105-110 | GeneOrGeneProduct | denotes | IL-10 | |
T64036 | 61-64 | GeneOrGeneProduct | denotes | TLR | |
T44809 | 214-217 | OrganismTaxon | denotes | cis |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-166 | Sentence | denotes | Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. |
T1 | 0-166 | Sentence | denotes | Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. |